Celyad Oncology OverviewCelyad Oncology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CYAD.
Quarterly EBIT
-$2.79M
↑ 40.77% YoY
As of Dec 31, 2024
Annual EBIT (TTM)
-$15.32M
↓ 153130% YoY
Trailing 12 months ending Dec 31, 2024
Celyad Oncology OverviewEBIT (Earnings Before Interest and Taxes) analysis for CYAD.
As of Dec 31, 2024
Trailing 12 months ending Dec 31, 2024